Published in:
Volume 6 / Year 2017 / Issue 2

Trends and challenges in biosimilars pricing and reimbursement policies in Europe and beyond

Page: 56-7

Abstract: Biosimilars policies are more controversial than those for generics. However, it is only a question of time before progress in biosimilars matches that of generics worldwide. Submitted: 21 April… Read More »

Go Back Print